University Hospital Leipzig, Germany
Professor Thomas Berg is Head of the Department of Gastroenterology and Rheumatology – Section Hepatology at the University Hospital Leipzig (Germany).
Erasmus Medical Centre, Rotterdam, The Netherlands
He received his training at the Academic Medical Centre in Amsterdam under the supervision of Prof. dr. Guido Tytgat and Prof. dr. Kees Huibregtse. His clinical and research activities focus on gastrointestinal oncology, hepato-pancreato-biliary diseases and interventional endoscopy, including endoscopic retrograde cholangio¬pancreatography (ERCP) and endoscopic ultrasound (EUS). He (co)-author of numerous peer reviewed articles in high ranking journals including the New England Journal of Medicine. He is a recognized international authority on the diagnosis and treatment of pancreatic diseases and has served as invited faculty at many international conferences and live endoscopy workshops. He is chairman of the Dutch Pancreatitis Study Group, council member end treasurer of the European Association of Gastroenterology, Endoscopy & Nutrition (EAGEN), and past council member and chairman of the Education Committee of United European Gastroenterology (UEG).
The Erasmus Medical Center is a large tertiary care 1320 bed academic hospital located in the city of Rotterdam the Netherlands. The department of Gastroenterology & Hepatology employs 16 staff members covering all the relevant GI & H specialty areas including hepatology (hepatitis, hepatocellular carcinoma, and liver transplantation), advanced endoscopy, GI oncology (esophageal, stomach, pancreas and colon), and inflammatory bowel disease and intestinal ischemia. The department has 16 fellows in training to become gastroenterologists and 2 foreign fellows for advanced endoscopy training. The department has its own dedicated laboratory facilities for translational and basic research. In total, 40 PhD students are working in the department to complete their PhD thesis on clinical, translational and basic research topics covering the various focus areas of the department.
Humanitas Research Hospital, Rozzano (Milan), Italy
Silvio Danese is a Gastroenterologist at Humanitas Research Hospital in Milan, and Professor
in gastroenterology at Humanitas University, Italy. He is Head of the Inflammatory Bowel
Disease (IBD) Center in the Division of Gastroenterology. Silvio Danese trained in
Gastroenterology at Policlinico Gemelli, Rome and graduated as a PhD, working from 2001 to
2004 in Dr. Claudio Fiocchi’s laboratory at the Case Western Reserve University, Cleveland,
His main research area of interest is the investigation of the fundamental mechanisms
underlying IBD pathogenesis, while his daily clinical activity is related to IBD service. He is
actively involved in many international clinical trials in IBD and has published more than 300
papers in several journals, including New England Journal of Medicine, Lancet,
Gastroenterology, Gut, Journal of Clinical Investigation.
He is a member of many organisations related to the IBD field, including the European
Crohn´s and Colitis Organization (ECCO), where from March 2016 is President elect. He is
also associate editor of Gut.
Vincent’s University Hospital, Dublin, Ireland
Georges Pompidou European Hospital, Paris, France
University Cancer Center Leipzig (UCCL), University Hospital Leipzig, Germany
1987 – 1993 Regensburg, Munich and Lausanne
1994 – 2002 Internal Medicine and Hematology/Oncology, Technical University of Munich, Germany
2002 – 2007 Hematology and Oncology, Technical University of Munich, Germany
2007 – 2009 National Center for Tumor Diseases (NCT), University of Heidelberg, Germany
2009 – 2012 Director of Hematology and Medical Oncology, Klinikum Braunschweig, Germany
Since 2012 Director of the University Cancer Center (UCCL), University of Leipzig, Germany
1994 Degree „Doctor medicinae“ (M.D.)
2000 Degree in „Internal Medicine”2003Degree in “Hematology and Medical Oncology”
2003 European Certification in Medical Oncology
2006 Habilitation (Ph.D. equivalent)
2010 Appointment as Associate Professor, Hannover
2012 Appointment as Full Professor, Leipzig
1997 German Society of Internal Medicine (DGIM)
2001 European Society for Medical Oncology (ESMO)
2001 German Society of Hemato-Oncology (GSHO)
2002 American Society of Clinical Oncology (ASCO)
2002 European Orgsanization of research and Treatment of Cancer (EORTC)
2004 German Cancer Society (DKG)
2013 International Gastric Cancer Association (IGCA)
2004 – 2008 Chairman of the “Esophageal and Gastric Cancer Working Group” of the AIO/German Cancer Society
2007 – 2013 Board of Directors of the AIO
2008 – 2014 Chairman of the Gastric and Esophageal Cancer Task Force of the EORTC
Since 2012 Chairman of the “Palliative Care” working group of the German Cancer Society
Since 2014 Secretary elect of the EORTC GI Tract Cancer Working Group
Since 2014 Executive Board (representative for hematology/oncology) of the German Society of Internal Medicine
Since 2014 Secretary of the German Cancer Society
Treatment of esophago-gastric cancer; Biomarker- and response-guided treatment; Palliative Care
Otto v. Guericke University, Magdeburg, Germany
He received his MD from the University of Bologna, Italy in 1975, and gained subsequent medical experience at the Regional Hospital of Bozen, Italy, and the University Hospital of Ulm, Germany (1978-1992), a Research Fellow at the Mayo Clinic GI Unit in Rochester, MN, USA. Professor Malfertheiner has been Chairman of the UEGF (2004) and President of the UEGW 2006 and of the Education Committee of the United European Gastroenterology Federation (UEGF). He is also the Editor of Digestive Diseases, Associate Editor of the American Journal of Gastroenterology, and a member of the Editorial Boards of several other journals; the European Journal of Gastroenterology, Helicobacter, Digestive Surgery, and the International Journal of Pancreatology. His main research interests are Helicobacter pylori infection and related diseases, chronic inflammation and carcinogenesis, gastric cancer, hepatocellular cancer, gastroesophageal reflux disease (GERD).
University Hospital KU Leuven, Belgium
A specialist in internal medicine, gastroenterology, and hepatology, he earned his medical degree from the Catholic University of Leuven as well as a PhD in the pathophysiology of esophageal varices. Current research interests include complications of cirrhosis, liver transplantation, and chronic hepatitis B and C viruses and polycystic liver disease. The author of more than 200 peer-reviewed manuscripts, Dr. Nevens is a board member of the Flemish Society of Gastroenterology and the Belgian Transplant Society, and is a member of the European and International Associations for the Study of the Liver and the American Association for the Study of Liver Diseases. He cofounded the Belgian Association of the Study of the Liver, and has served as an EASL board member and president of the Belgian Liver and Intestinal Transplantation Committee.
St. John of God Hospital, Regensburg, Germany
Medical Center for Postgraduate Education and Institute of Oncology, Warsaw, Poland
Gastroenterology training completed 1992.
Research fellow at University College London, UK, 1992-93.
Board member of European Association of Gastroenterology, Endoscopy and Nutrtion.
Presently Head of the Department of Gastroenterology, Medical Center for Postgraduate Education and Institute of Oncology, Warsaw. Research interests: digestive endoscopy, colorectal cancer screening, Barrett’s oesophagus.
1) Regula J et al: Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. NEJM 2006;355:1863-72
2) Kaminski MF, Regula J et al: Quality indicators for colonoscopy and the risk of interval cancer. NEJM 2010;362:1795-803
Leeds Teaching Hospitals, Leeds, UK
He was born in Sweden and qualified from Leicester University in 1987. He undertook his postgraduate education in Leicester and in Leeds. His MD was dedicated to inflammatory bowel disease. Dr Rembacken was appointed Consultant Gastroenterologist, Honorary Lecturer at Leeds University and Training Lead for Endoscopy in Leeds in 2005. Although his MD was entitled “The role of Escherichia coli in inflammatory bowel disease”, his heart was always in endoscopy! Dr Rembacken has a particular interest in therapeutic endoscopy including EMR and ESD techniques. Positions BSG Endoscopy committee BSG Research committee BSG Information committee European Society of Gastrointestinal Endoscopy board World Association of Digestive Endoscopy (OMED) – MST working group lead UEG eLearning editor